Brief: HLS Therapeutics Q2 Loss Per Share $0.02

HLS Therapeutics

15/08/2018 11:34

Aug 15 (Reuters) - HLS Therapeutics Inc  HLS.V :
    * HLS THERAPEUTICS ANNOUNCES Q2 2018 FINANCIAL RESULTS
    * Q2 LOSS PER SHARE $0.02
    * SETS QUARTERLY DIVIDEND OF C$0.05PER SHARE
    * QTRLY TOTAL REVENUE $16.3 MILLION VERSUS $18.9 MILLION
    * HLS THERAPEUTICS - ENTERED NEW SENIOR SECURED TERM LOAN
WITH
SYNDICATE OF BANK LENDERS
    * PRINCIPAL AMOUNT OF NEW SENIOR SECURED TERM LOAN IS $100.0
MILLION
    * IN ADDITION, THERE IS A $25.0 MILLION REVOLVING FACILITY
THAT IS
UNDRAWN ON CLOSING
    * HLS THERAPEUTICS - MAY ALSO REQUEST TO BE PROVIDED WITH
INCREMENTAL LOANS, FOR MAXIMUM ADDITIONAL LOAN OF $100 MILLION
    * MATURITY DATE OF LOAN IS AUGUST 15, 2023
    * PROCEEDS FROM NEW SENIOR SECURED TERM LOAN,AVAILABLE CASH
BALANCES USED TO REPAY CO'S EXISTING SENIOR SECURED TERM LOAN IN
FULL

Source text for Eikon:  ID:nCNWDYwZXa 
Further company coverage:  HLS.V 

 ((Reuters.Briefs@thomsonreuters.com;))